Dhanuka Agritech Limited’s Board of Directors has approved a significant investment of up to ₹200 Crore for the establishment of a new pesticide manufacturing unit in Nagpur, Maharashtra. The company also greenlit a loan of up to ₹15 Crore to its employee stock benefits trust for implementing its stock appreciation rights plan. Unaudited financial results for the quarter ended June 30, 2026, were also approved.
Expansion Plans Approved
Dhanuka Agritech Limited’s Board of Directors convened on August 3, 2026, approving key strategic initiatives to drive future growth. A significant development was the approval for the establishment of a new pesticide manufacturing unit in Nagpur, Maharashtra, with an investment earmarked at up to ₹200 Crore (Rupees Two Hundred Crore Only). This expansion is intended to enhance production capacity and strengthen the company’s market presence.
New Manufacturing Unit Details
The proposed manufacturing unit in Nagpur is projected to add a capacity of 23,000 MT per annum. The project is expected to become operational by March/April 2028. The investment will be financed through internal accruals and/or debt. The strategic location in Nagpur is intended to improve logistical efficiency, reduce lead times to market, and leverage Maharashtra’s attractive industrial policies and the city’s development as a central logistics hub.
Employee Stock Plan Funded
In addition to the manufacturing expansion, the Board also approved the granting of a loan of up to ₹15 Crore to the proposed Dhanuka Employee Stock Benefits Trust. This fund will be used for the acquisition of equity shares from the open market and the administration of the “Dhanuka Stock Appreciation Rights Plan, 2026” (SAR 2026), in line with SEBI regulations.
Quarterly Financials Reviewed
The Board also reviewed and approved the Unaudited Financial Results for the quarter ended June 30, 2026. The company reported a Profit/Loss for the period after tax of ₹3,630.44 Lakhs. The total comprehensive income for the period stood at ₹9,870.90 Lakhs. Basic EPS for the quarter was ₹8.06, and diluted EPS was also ₹8.06.
Financial Highlights (Quarter Ended June 30, 2026)
Key financial figures for the quarter ended June 30, 2026, include:
- Revenue from Operations: ₹46,192.81 Lakhs
- Total Income: ₹47,079.09 Lakhs
- Total Expenses: ₹42,221.73 Lakhs
- Profit Before Tax: ₹4,857.36 Lakhs
- Profit After Tax: ₹3,630.44 Lakhs
The limited review report for these unaudited financial results was also submitted.
Source: BSE
